LPA A.I CyberSecurity Scoring
30/12/2025
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for LGC in partnership with ATCC in 2026.
No incidents recorded for LGC in partnership with ATCC in 2026.
No incidents recorded for LGC in partnership with ATCC in 2026.
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
Latest updates, reports, and threat intel affecting the global network.
FOSSBilling is a free, open-source billing and client management system. In versions 0.5.6 through 0.7.2, when a `ClientPasswordReset` record already exists for a client (from a previous unexpired reset request), subsequent calls to the `reset_password` guest API endpoint reuse the existing token instead of generating a new one. The 15-minute validity window is anchored to the first request's `created_at` timestamp, not the time of the most recent email. An attacker who obtained the original reset link remains able to use it even after the victim requests a new reset, because the original token is never invalidated or rotated. Version 0.8.0 patches the issue. Some workarounds are available. Configure a reverse proxy (e.g., Nginx, Apache, Cloudflare) to apply per-IP rate limiting to the `/client/reset-password` endpoint to minimize the window of opportunity, and/or manually clear expired `client_password_reset` records from the database after a client reports a suspected compromise.
FOSSBilling is a free, open-source billing and client management system. Versions prior to 0.8.0 allow a low-privileged staff account to grant arbitrary module permissions to itself through the admin API, resulting in persistent privilege escalation. A staff user that only has `staff.create_and_edit_staff` can call `/api/admin/staff/permissions_update` targeting their own account and write any permission structure, bypassing the intended role-based access control boundary. Version 0.8.0 patches the issue. Some workarounds are available. Restrict the `staff.create_and_edit_staff` permission to only highly trusted staff members and/or use a reverse proxy or WAF to restrict access to `/api/admin/staff/permissions_update` to specific trusted roles.
FOSSBilling is a free, open-source billing and client management system. Versions 0.5.3 through 0.7.2 allow authenticated clients to both read and reset API key service secrets for orders that are no longer in an `active` state (e.g., `suspended`, `canceled`). The root cause is missing order-state validation in two client API endpoints, despite an `isActive()` helper already existing in the `Serviceapikey` module and the frontend UI correctly gating access on `order.status == 'active'`. Version 0.8.0 contains a fix. Some workarounds are available. If the `Serviceapikey` module is not needed, uninstall it to remove the affected endpoints. One may also use a reverse proxy or WAF to restrict access to `/api/client/order/service` and `/api/client/serviceapikey/reset` based on application-level order-state logic.
FOSSBilling is a free, open-source billing and client management system. Versions prior to 0.8.0 allow low-privileged staff accounts to perform unauthorized actions via admin API endpoints. The root cause is a combination of the `can_always_access` module flag (which grants all staff access to certain modules) and insufficient permission checks or unsafe parameter handling on individual endpoints. Version 0.8.0 contains a fix. Some workarounds are available. Restrict staff accounts to only those who need access to sensitive settings and/or use a reverse proxy or WAF to restrict access to the affected endpoints to trusted IP addresses or higher-privilege roles.
FOSSBilling is a free, open-source billing and client management system. In versions 0.5.6 through 0.7.2, when the "Require Email Confirmation" setting is enabled, a logged-in client with an unverified email address (`email_approved = 0`) can access all client-area pages (e.g. `/client/balance`, `/client/order/list`, `/client/invoice`) and read real account data, including wallet balances and transaction history. The API-side enforcement correctly restricts unverified clients to only profile-related endpoints, but the page-side enforcement is overly permissive, allowing any request whose path starts with `/client`. Version 0.8.0 contains a fix. No known workarounds that don't involve modifying the source code are available.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.